Skip to main content
BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
8.30
+0.10 (1.22%)
Apr 3, 2025, 3:54 PM EST

BioStem Technologies Revenue

BioStem Technologies had revenue of $82.56M in the quarter ending September 30, 2024, with 2,258.93% growth. This brings the company's revenue in the last twelve months to $210.49M, up 3,445.26% year-over-year. In the year 2023, BioStem Technologies had annual revenue of $16.69M with 142.69% growth.

Revenue (ttm)
210.49M
Revenue Growth
+3,445.26%
P/S Ratio
0.63
Revenue / Employee
6.38M
Employees
33
Market Cap
136.97M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202316.69M9.81M142.69%
Dec 31, 20226.88M2.53M58.38%
Dec 31, 20214.34M4.03M1,284.88%
Dec 31, 2017313.45K-293.78K-48.38%
Dec 31, 2016607.22K455.69K300.71%
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 16.04M
Endo Inc. 1.76B
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
Northwest Biotherapeutics 1.38M
American Oncology Network 1.76B
Longduoduo Company 6.01M
Revenue Rankings

BioStem Technologies News

More News